Last reviewed · How we verify
Infuvite Adult (Colecalciferol)
At a glance
| Generic name | Colecalciferol |
|---|---|
| Also known as | Vitamin D3, CAS No: 67-97-0, ATC code: A11CC05, (Dekristol®, Swiss-Caps, Switzerland), Vitamin D |
| Sponsor | Novartis |
| Drug class | Vitamin D |
| Target | Vitamin D3 receptor |
| Modality | Small molecule |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
| First approval | 2000 |
Approved indications
- Glucocorticoid Induced Osteoporosis
- Hypocalcemia
- Hypogonadal Osteoporosis in Males
- Hypoparathyroidism
- Osteomalacia
- Osteoporosis
- Postmenopausal osteoporosis
- Prevention of dental caries
- Rickets
- Vitamin D Dependent Rickets
- Vitamin D deficiency
- Vitamin deficiency
Common side effects
- Toxicity to various agents
- Completed suicide
- Drug abuse
- Pemphigus
- Systemic lupus erythematosus
- Glossodynia
- Drug interaction
- Alopecia
- Abdominal discomfort
- Rheumatoid arthritis
- Arthropathy
- Hand deformity
Key clinical trials
- Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric Participants (PHASE2)
- Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With Obesity (PHASE2)
- Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors
- Acute Vitamin D Supplementation on Testosterone in Females (NA)
- Association Between Benign Paroxysmal Positional Vertigo and Vitamin D Deficiency .
- PRESS -PAR: Early Detection and PREvention of Symptomatic postSurgical hypoPARathyroidism After Thyroid Surgery" (NA)
- Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients (PHASE2)
- Effect of the Consumption of Cookies Enriched With Plant Proteins and of a Vitamin D Supplement on the Progression of Sarcopenia in the Elderly (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Infuvite Adult CI brief — competitive landscape report
- Infuvite Adult updates RSS · CI watch RSS
- Novartis portfolio CI